Radioimmunotherapy of PANC-1 human pancreatic cancer xenografts in NOD/SCID or NRG mice with Panitumumab labeled with Auger electron emitting, 111In or β-particle emitting, 177Lu

Overview of attention for article published in EJNMMI Radiopharmacy and Chemistry, November 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 13 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 11 publications that cite this research output.

11

The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.

Adjuvant Auger Electron-Emitting Radioimmunotherapy with [111In]In-DOTA-Panitumumab in a Mouse Model of Local Recurrence and Metastatic Progression of Human Triple-Negative Breast Cancer

Article in Molecular Pharmaceutics (November 2023)

Relative Biological Effectiveness (RBE) of [64Cu]Cu and [177Lu]Lu-NOTA-panitumumab F (ab')2 radioimmunotherapeutic agents vs. γ-radiation for decreasing the clonogenic survival in vitro of human pancreatic ductal adenocarcinoma (PDAC) cells

Article in Nuclear Medicine and Biology (July 2023)

A Multifunctional Porous Silicon Nanocarrier for Glioblastoma Treatment

Article in Molecular Pharmaceutics (December 2022)